Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

BACKGROUND: Targeting CTLA-4 is a recent strategic approach in cancer control: blocking CTLA-4 enhances an antitumor immunity by promoting T-cell activation and cytotoxic T-lymphocyte proliferation. This induction of a tolerance break against the tumor may be responsible for immune-related adverse e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Med
Hlavní autoři: Bertrand, Anne, Kostine, Marie, Barnetche, Thomas, Truchetet, Marie-Elise, Schaeverbeke, Thierry
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559965/
https://ncbi.nlm.nih.gov/pubmed/26337719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0455-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky